中国医药

- 600056

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2024  2023  2022  2021  2020  2019  2018  2017  2016  2015  2014 
中国医药(600056) 利润表
单位:万元
报表日期2024-03-312023-12-312023-09-302023-06-302023-03-31
一、营业总收入877,484.593,882,443.052,979,676.752,162,497.121,253,066.32
营业收入877,484.593,882,443.052,979,676.752,162,497.121,253,066.32
二、营业总成本851,387.643,750,189.512,868,495.192,072,080.251,209,366.86
营业成本787,133.413,444,081.372,649,590.261,922,111.881,129,749.20
营业税金及附加2,294.1212,740.259,563.956,753.403,238.08
销售费用30,264.94161,089.95121,001.3786,818.8946,335.14
管理费用24,079.03109,520.3874,269.0548,644.1123,002.63
财务费用4,366.8911,203.826,722.952,384.874,324.15
研发费用3,249.2511,553.737,347.625,367.092,717.67
资产减值损失----------
公允价值变动收益-44.3198.4933.433.2782.78
投资收益365.17-1,579.222,781.843,140.761,530.30
其中:对联营企业和合营企业的投资收益1,090.537,704.316,571.375,774.872,087.37
汇兑收益----------
三、营业利润27,553.22167,233.42110,548.8987,314.2940,684.49
加:营业外收入92.332,541.881,469.64745.6921.17
减:营业外支出288.945,719.751,103.48629.9144.62
其中:非流动资产处置损失----------
四、利润总额27,356.61164,055.55110,915.0587,430.0640,661.03
减:所得税费用7,068.5339,843.5132,548.7719,754.738,602.80
五、净利润20,288.08124,212.0578,366.2867,675.3332,058.23
归属于母公司所有者的净利润14,560.00104,803.9159,411.0654,354.7726,877.01
少数股东损益5,728.0919,408.1318,955.2213,320.575,181.22
六、每股收益
基本每股收益(元/股)0.09730.70060.39720.36340.1797
稀释每股收益(元/股)0.09730.70060.39720.36340.1797
七、其他综合收益136.15-4,068.6670.66161.9322.55
八、综合收益总额20,424.23120,143.3878,436.9467,837.2632,080.79
归属于母公司所有者的综合收益总额14,696.14100,733.9159,481.7254,516.6926,899.57
归属于少数股东的综合收益总额5,728.0919,409.4818,955.2213,320.575,181.22
下载全部历史数据到excel中 返回页顶